Former Bristol-Myers Squibb executive indicted
Pharma Compliance Alert, April 30, 2008
Andrew G. Bodnar, MD, a former senior executive vice president for Bristol-Myers Squibb, faces charges of lying to the Federal Trade Commission (FTC), according to a Department of Justice (DOJ) press release.
Bodner is accused of negotiating a secret pact between Bristol-Myers Squibb and Apotex, a Canadian generic drug maker, and then hiding the deal from federal regulators. At a 2006 meeting, Bodnar reassured Apotex that Bristol-Myers Squibb would not launch its own generic version of Plavix if Apotex agreed to settle litigation over the validity of the Plavix patent, according to the DOJ.
At the time, Bristol-Myers Squibb was under a consent decree that required it to submit any proposed patent settlements for review and advisory approval by the FTC. The FTC told Bristol-Myers Squibb that it would not approve the settlement of the Plavix lawsuit if Bristol-Myers Squibb promised not to launch its own generic version of Plavix.
Bodnar faces a maximum sentence of five years of imprisonment and a fine of $250,000.
Comments
0 comments on “Former Bristol-Myers Squibb executive indicted ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Searched